Maurits A. Sikking - Publications

Insights Into the Natural History of Recurrent Myocarditis, A Multicenter International Study (Re-Myo Study).

Journal: Journal of the American Heart Association

Published: May 06, 2026

Improved Outcome up to Ten Years after Intravenous Immunoglobulin Therapy in Patients with Dilated Cardiomyopathy.

Journal: European journal of heart failure

Published: December 10, 2025

Temporal variability of the electromechanical window in long-QT syndrome and drug-induced QT prolongation: Value for enhanced arrhythmia-risk assessment.

Journal: Heart rhythm

Published: November 12, 2025

Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy.

Journal: Circulation. Heart failure

Published: September 24, 2025

Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: August 08, 2025

High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: July 09, 2025

Clinical characteristics and outcomes of cardiomyopathies related to immune-mediated diseases.

Journal: European journal of heart failure

Published: June 15, 2025

Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy.

Journal: European journal of heart failure

Published: May 23, 2025

Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.

Journal: Circulation research

Published: October 21, 2024

How Clonal Hematopoiesis Can Predict Treatment Response in Patients With Dilated Cardiomyopathy.

Journal: JACC. Basic to translational science

Published: September 19, 2024

Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study.

Journal: European heart journal. Quality of care & clinical outcomes

Published: August 27, 2024

Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease.

Journal: JACC. Heart failure

Published: June 07, 2024